Skip to main content
COLLEGIUM PHARMACEUTICAL, INC logo

COLLEGIUM PHARMACEUTICAL, INC — Investor Relations & Filings

Ticker · COLL ISIN · US19459J1043 LEI · 54930049FXZMTLW8D496 US Manufacturing
Open in API
Filings indexed 821 across all filing types
Latest filing 2026-06-01 Share Issue/Capital Cha…
Country US United States of America
Listing US COLL

About COLLEGIUM PHARMACEUTICAL, INC

https://www.collegiumpharma.com/

Collegium Pharmaceutical, Inc. is a diversified biopharmaceutical company that develops and commercializes medicines for people with serious medical conditions. The company is focused on building a portfolio of differentiated medications. Its primary area of expertise is in pain management, where it develops products with abuse-deterrent properties designed to be safer alternatives for patients and the community.

Recent filings

Filing Released Lang Actions
FORM S-8
Share Issue/Capital Change Classification · 95% confidence The document is a Form S-8 Registration Statement filed with the SEC to register additional shares under the company’s Employee Stock Purchase Plan. This is a direct share issuance/capital change filing rather than an annual report, earnings release, or management commentary. It specifically registers new shares, fitting the ‘Share Issue/Capital Change’ category.
2026-06-01 English
FORM S-8
Regulatory Filings Classification · 90% confidence The document is an SEC Form S-8 registration statement under the Securities Act of 1933, used to register shares for an employee inducement plan. It is not an annual or quarterly financial report, earnings release, proxy statement, or other specialized filing category. There is no specific category for Form S-8, so under the fallback rules it should be classified as a general regulatory compliance filing.
2026-06-01 English
FORM 8-K
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a Form 8-K “Current Report” filed under Item 5.07 “Submission of Matters to a Vote of Security Holders,” containing detailed vote tallies from the 2026 Annual Meeting. This matches the category for “Declaration of Voting Results & Voting Rights Announcements” (DVA).
2026-05-15 English
8-K - COLLEGIUM PHARMACEUTICAL, INC (0001267565) (Filer)
Regulatory Filings Classification · 91% confidence The document is a Form 8-K “Current Report” filed with the U.S. Securities and Exchange Commission, covering multiple items (asset acquisition completion, officer departures, Regulation FD disclosure, exhibits). It is not itself the substantive acquisition agreement (Exhibit 2.1 is attached by reference), nor a standalone M&A proxy or tender offer communication. It primarily serves as a regulatory compliance filing, reporting material corporate events. Therefore, the most appropriate category is Regulatory Filings (RNS).
2026-05-12 English
10-Q - COLLEGIUM PHARMACEUTICAL, INC (0001267565) (Filer)
Interim / Quarterly Report Q1 2026
2026-05-07 English
8-K - COLLEGIUM PHARMACEUTICAL, INC (0001267565) (Filer)
Report Publication Announcement Classification · 92% confidence The document is a Form 8-K “Current Report” that is short (~3,600 characters) and does not itself contain financial statements or substantive data, but rather notes that a press release and an earnings presentation are attached as exhibits. Under the “Menu vs. Meal” rule, documents under 5,000 characters that simply announce the publication or attachment of reports should be classified as Report Publication Announcements (RPA), not as the reports themselves or another category.
2026-05-07 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.